AMF Tjanstepension AB Acquires Shares of 5,505 Intuitive Surgical, Inc. (NASDAQ:ISRG)

AMF Tjanstepension AB acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 5,505 shares of the medical equipment provider’s stock, valued at approximately $2,873,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP raised its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the period. Onefund LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. raised its holdings in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares in the company, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,579 shares of company stock worth $7,756,844. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on ISRG shares. Truist Financial raised their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Down 3.8 %

Shares of ISRG opened at $518.26 on Friday. The firm has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average of $571.36 and a 200-day moving average of $531.53. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.